Senolytic treatment with dasatinib and quercetin in aged mice produced measurable remodeling across immune, fibrotic, and metabolic pathways, with sustained intervention showing greater efficacy than short-term exposure. This work maps the molecular cascades underlying senolytic action and establishes timing as a critical variable in cellular rejuvenation.
Key Points
- Senolytics trigger coordinated immune, fibrotic, and metabolic tissue remodeling
- Prolonged senolytic intervention outperforms early, short-term treatment cycles
- Single-cell profiling reveals cell-type-specific responses across tissues
Longevity Analysis
Senescent cells accumulate with age and drive chronic inflammation, fibrosis, and metabolic dysfunction. This research demonstrates that senolytic agents work not as single-pathway interventions but as initiators of coordinated systemic remodeling—removing senescent cells triggers downstream recalibration of immune surveillance, tissue repair capacity, and energy metabolism. The finding that prolonged treatment exceeds short-term intervention suggests that cellular clearance requires sustained engagement rather than episodic exposure, informing how future senolytic protocols should be structured to maximize tissue-level benefit.
Original published by Nature Aging, by Jing Hou.